The importance of L-arginine metabolism in melanoma: An hypothesis for the role of nitric oxide and polyamines in tumor angiogenesis

Free Radical Biology and Medicine

Volumn 22, Issue 3, 1997, Pages 573-578

  Joshi, Minakshi ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; Free radicals; L arginine metabolism; Melanoma; Nitric oxide; Nitric oxide synthase; Ornithine decarboxylase; Polyamines

Indexed keywords

ARGININE; FREE RADICAL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; ORNITHINE DECARBOXYLASE; POLYAMINE;

AMINO ACID METABOLISM; ANGIOGENESIS; ARTICLE; BLOOD VESSEL TONE; CELL PROLIFERATION; CHICK EMBRYO; ENDOTHELIUM CELL; HUMAN; MELANOMA; METASTASIS; NONHUMAN; POLYAMINE SYNTHESIS; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR VASCULARIZATION;

ARGININE; HUMANS; MELANOMA; MODELS, BIOLOGICAL; NEOVASCULARIZATION, PATHOLOGIC; NITRIC OXIDE; POLYAMINES; SKIN;

EID: 0031023120     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(96)00339-5     Document Type: Article

References (63)

1. Folkman J. Angiogenesis: A new concept for therapy of solid tumors. Annals. of Surgery. 175:1972;409-416.
2. Folkman J. Clinical applications of research on angiogenesis. Seminars in Medicine of the Beth Israel Hospital. 333:(26):1995;1757-1763.
3. Arbiser JL. Angiogenesis and the skin: A primer. J. Am. Acad. Of Dermatology. 34:(3):1996;486-497.
4. Rak JW, Hegmann EJ, Kerbel RS. The role of angiogenesis in tumor progression and metastasis. Adv. In Molec. and Cell. Biology. 7:1993;205-251.
5. Denijn M, Ruiter DJ. The possible role of angiogenesis in the metastatic potential of human melanoma. Melanoma Res. 3:(1):1993;5-14.
6. Fidler IJ. Critical factors in the biology of human cancer metastasis: 28th G.H.A Clowes Memorial Award Lecture. Canc. Res. 50:1990;6130-6138.
7. Nicolson GL. Organ specificity of tumor metastasis: role of preferential adhesion invasion and growth of malignant cells at specific secondary sites. Canc. Metastasis Rev. 7:1988;143-188.
8. Moncada S, Palmer RMJ, Higgs EA. Biosynthesis of nitric oxide from L-arginine: a pathway for the regulation of cell function and communication. Biochem Pharmacol. 38:1989;1709-1715.
9. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide physiology, pathology and pharmacology. Pharmacol Rev. 43:1991;109-142.
10. Lancaster JR. Nitric oxide in cells. American Scientist. 80:1992;248-259.
11. Tabor CW, Taber H. Polyamines. Ann. Rev. Biochem. 53:1984;749-790.
12. Pegg AE. Polyaminemetabolism and its importance in neoplastic growth and as a target for chemotherapy. Cancer Res. 48:1988;759-774.
13. Pegg AE, McCann PP. Polyamine metabolism and function. Am. J. Physiol. 243:1982;C212-C221.
14. Charles IG, Palmer RMJ, Hickery MS, Bayliss MT, Chubb AP, Hall VS, Moss DW, Moncada S. Cloning, characterization and expression of a cDNA encoding an inducible NO synthase from the human chondrocyte. Proc Natl Acad. Sci. USA. 90:1993;11419-11423.
15. Janssens SP, Shimouchi A, Quertermous T, Bloch DB, Bloch KD. loning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase. J. Biol. Chem. 267:1992;14519-14522.
16. Nakane M, Schmidt H, Pollock JS, Fostermann U, Murad F. Cloned human brain nitric oxide synthase is highly expressed in skeletal muscle. FEBS Lett. 6:1993;3051-3064.
17. Bredt DS, Hwang PM, Glatt CE, Lowenstein C, Reed RR, Snyder SH. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature. 351:1991;714-718.
18. Lamas S, Marsden PA, Li GK, Tempst P, Michel T. Endothelial nitric oxide synthase: Molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc. Natl. Acad. Sci. USA. 89:1992;6348-6352.
19. Lowenstein CJ, Glatt CS, Bredt DS, Snyder SH. Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme. Proc. Natl. Acad. Sci. USA. 89:1992;6711-6715.
20. Xie QW, Cho HJ, Calaycay J, Mumford RA, Swiderek KM, Lee TD, Ding A, Troso T, Nathan C. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science. 256:1992;225-228.
21. Lyons CR, Orloff GJ, Cunningham JM. Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line. J. Biol. Chem. 267:1992;6370-6374.
22. O'Brien TG, Hietala O, O'Donnel K, Holmes M. Activation of mouse epidermal tumor ornithine decarboxylase by GTP: evidence for different catalytic forms of the enzyme. Proc. Natl. Acad. Sci USA. 84:1987;8927-8931.
23. Takigawa W, Ishida H, Takano T, Suzuki F. Polyamines and differentiation: induction of ornithine decarboxylase by parathyroid hormone is a good marker of differentiated chondrocytes. Proc. Natl. Acad. Sci USA. 77:1980;1481-1485.
24. Janne J, Poso H, Raine A. Polyamines in rapid growth and cancer. Biochem. Biophys. Acta. 473:1978;241-293.
25. Heby O. Role of polyamines in the control of cell proliferation and differentiation. Differentiation. 19:1981;1-20.
26. Kitani T, Fujisawa H. Purification and characterization of antizyme inhibitor of ornithine decarboxylase from rat liver. Biochem. Biophys. Acta. 991:(1):1989;44-49.
27. Blachier F, M'Rabet-Touil H, Posho L, Morel M, Bernard F, Darcy-Virllon B, Duee PH. Polyamine metabolism in enterocytes isolated from newborn pigs. Biochem. Biophys. Acta. 1175:1992;21-26.
28. Blachier F, Darcy-Virllon B, Sener A, Duee PH, Malaisse WJ. Arginine metabolism in rat enterocytes. Biochem. Biophys. Acta. 1092:(3):1991;304-310.
29. Ginty DD, Marlowe M, Pekala PH, Seidel ER. Multiple pathways for the regulation of ornithine decarboxylase in intestinal epithelial cells. Am. J. Physiol. 258:1990;G454-G460.
30. Porter CW, Pegg AE, Gantis B, Madhabala R, Bergeron RJ. Combined regulation of ornithine and S-adenosylmethionine decarboxylases by spermine and the spermine analogue NI NI2-bis(ethyl) spermine. Biochem. J. 268:(1):1990;207-212.
31. Warren JB, Loi RK, Coughlan ML. Involvement of nitric oxide synthase in the delayed vasodilator response to ultraviolet light irradiation of rat skin in vivo. Br. J. Pharmacol. 109:(3):1993;802-806.
32. Warren JB. Nitric oxide and human skin blood flow responses to acetylcholine and ultraviolet light. FASEB J. 8:(2):1994;247-251.
33. Ialenti A, Ianaro A, Moncada S, DiRosa M. Modulation of acute inflammation by endogenous nitric oxide. Eur. J. Pharmacol. 211:(2):1992;177-182.
34. Teixeira MM, Williams TJ, Hellewell PG. Role of prostaglandins and nitric oxide in acute inflammatory reactions in guinea-pig skin. Br. J. Pharmacol. 110:(4):1993;1515-1521.
35. Hibbs JB Jr., Taintor RR, Vavrin Z, Rachlin EM. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem. Biophys. Res Commun. 157:1988;87-94.
36. Marletta MA, Yoon PS, Iyengar R, Leaf CD, Wishnock JS. Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochem. 27:1988;8706-8711.
37. Stuehr DJ, Nathan CF. Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J. Exp. Med. 169:1989;1543-1555.
38. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 1992;3051-3064.
39. Vitolo D, Zerbe T, Kanbour A, Dahl C, Herberman RB, Whiteside TL. Expression of mRNA for cytokines in tumor infiltrating mononuclear cells in ovarian adenocarcinoma and invasive breast cancer. Int. J. Cancer. 51:1992;573-580.
40. Mills CD. Molecular basis of "suppressor" macrophages. Arginine metabolism via the nitric oxide synthase pathway. J. Immunol. 146:1991;2719-2723.
41. Simmons RL. Characterization of the immunosuppressive effects of nitric oxide in graft versus host disease. J. Immonol. 151:1993;1508-1518.
42. Pipili-Synetos E, Sakkouia E, Maragoudakis ME. Nitric oxide is involved in the regulation of angiogenesis. J. Pharmacol. 108:1993;855-857.
43. Pipili-Synetos E, Sakkouia E, Haralobopoulos G, Andriopoulou P, Peristeris P, Maragoudakis ME. Evidence that nitric oxide is an endogenous antiangiogenic mediator. Br. J. Pharmacol. 111:1993;894-902.
44. Yang W, Ando J, Korenaga R, Toyo-oka T, Kamiya A. Exogenous nitric oxide inhibits proliferation of cultured vascular endothelial cells. Biochem. Biophys. Res. Commu. 203:1994;1160-1167.
45. Ziche M, Morbidelli L, Masini E, Amerini S, Granger HJ, Maggi CA, Geppetti P, Ledda F. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J. Clin. Invest. 94:1994;2036-2044.
46. Buttery LDK, Springali DR, Andrade SP, Riveros-Moreno V, Hart I, Piper PJ, Polak JM. Induction of nitric oxide synthase in the neo-vasculature of experimental tumors in mice. J. Pathol. 171:1993;311-319.
47. Maragos CM, Wang JM, Harbie JA, Oppenheim JJ, Keefer LK. Nitric oxide/nucleophile complexes inhibit the in vitro proliferation of A375 melanoma cells via nitric oxide release. Cancer Res. 53:1993;564-568.
48. Andrade SP, Hart I, Piper PJ. Inhibitors of nitric oxide synthase selectively reduce flow in tumor-associated neovasculature. Br. J. Pharmacol. 107:1992;1092-1095.
49. Boutwell RK, O'Brien TG, Verma AK, Weekes RG, DeYoung LM, Ashendel CL, Astrup EG. The indication of ornithine decarboxylase activity and its control in mouse skin epidermis. Adv. Enzyme Regul. 17:1979;89-112.
50. Scalabrino G, Ferioli ME. Polyamines in mammalian tumors. Part 1; Part 2. Adv. Cancer Res; Adv. Cancer Res. 35; 36:1981; 1982;151; 1-268; 102.
51. Verma A, Boutwell RK. Inhibition of carcinogenesis by inhibitors of putrescine biosynthes. McCann PP, Pegg AE, Sjoerdsma A. Inhibition of Polyamine Metabolism. Biological Significance and Basis for new Therapies. 1987;249-258 Academic Press, Orlando, FL.
52. Nakadate T, Aizu E, Yamamoto S, Fujiki H, Sugimura T, Kato R. Inhibition of teleocidin caused epidermal ornithine decarboxylase induction by phospholipase A2-, cyclooxygenase- and lipoxygenase inhibitors. Jpn. J. Of Pharmacol. 37:1985;253-258.
53. Takigawa M, Enomoto M, Nishide Y, Pan- HO, Kinashita A, Suzuki F. Tumor angiogenesis and polyamines: α-difluoromethylornithine , an irreversible inhibitor of ornithine decarboxylase, inhibits B16 melanoma-induced angiogenesis in ovo and the proliferation of vascular endothelial cells in Vitro. Cancer Res. 50:1990;4131-4138.
54. Berse B, Brown LF, Van De Water L. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages and tumors. Molec. Biol. of the Cell. 3:1992;211-220.
55. Okamura K, Morimoto A, Hamanaka R. A model system for tumor angiogenesis: involvement of transforming growth factor beta in tube formation of human microvascular endothelial cells induced by esophageal cancer cells. Biochem. et Biophys. Commu. 186:1992;1471-1479.
56. Schott RJ, Morrow LA. Growth factors and angiogenesis. Cardiovas. Res. 27:(7):1993;1155-1161.
57. Good DJ, Polverini PJ, Rastinejad F. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc. Natl. Acad. Of Sci. USA. 87:1990;6624-6628.
58. Ray JM, Stetler-Stevenson WG. The role of matrix metalloproteases and their inhibitors in tumor invasion, metastasis and angiogenesis. Eur. Respiratory J. 7:(11):1994;2062-2072.
59. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell. 79:1994;315-328.
60. Joshi M, Strandhoy J, White W. Nitric oxide synthase activity is up-regulated in melanoma cell lines: A potential mechanism for metastasis formation. Melanoma Research. 6:(2):1996;121-126.
61. Joshi M. Nitric oxide synthase activity is up regulated in melanoma cell lines: A potential mechanism for metastases formation. Oxygen '95. 2nd Annual Meeting of The Oxygen Society, Pasadena, California. November 16-20, Abs 3-67, pg 121, Nov. 1995.
62. Yang BL and Joshi M. The role of L-arginine metabolites in DNA synthesis of melanoma cell lines. (Abstract). Photocarcinogenesis: Mechanisms, Models and Human Health Implications. The Mayflower Hotel, Washington, D.C. October 27-28, 1995.
63. Joshi, M; White, WL. A Radial growth phase Human Melanoma cell line and Tumorigenic Variants of The Same Cell line Differentially Express Neuronal Nitric Oxide Synthase. J. Invest. Dermatology. 106(4):854-Abs 290.; 1996.